[144] InfuSystem Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

InfuSystem Holdings, Inc. (INFU) filed a Form 144 notifying an intended open-market sale of 5,752 common shares through Charles Schwab with an aggregate market value of $56,455. The filing states the shares were originally acquired on 08/01/2017 via open-market purchase and payment in cash. The proposed approximate sale date is 08/22/2025, and the filing reports 20,425,964 shares outstanding for the issuer. No securities of the issuer were reported sold by the same person in the past three months. The filer affirms they are not aware of any undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing an intended open-market sale of a small block of shares acquired in 2017; appears non-material.

The filing documents a proposed sale of 5,752 common shares valued at $56,455, executed through Charles Schwab and originating from an open-market purchase on 08/01/2017. Given the reported 20,425,964 shares outstanding, this block represents a de minimis portion of the float. The filer also certifies absence of undisclosed material adverse information. For investors, this reads as a routine disclosure of a secondary sale rather than a company-specific event that would materially affect valuation.

Corporate Governance Specialist

TL;DR: Standard Rule 144 notification for compliance; no indication of coordinated insider signal or material disclosure.

The Form 144 provides required compliance details: broker, acquisition date, payment method, and planned sale date. The acquisition was paid in cash and there are no reported sales in the prior three months by the same person, reducing signs of accelerated disposal. The filer’s attestation regarding material information aligns with required certifications. From a governance perspective, this is a routine transparency filing rather than evidence of emergent corporate issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	5752	56455.00	20425964	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2017	Open Market Purchase	Open Market			5752	08/01/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does INFU's Form 144 disclose?

The filing discloses an intended open-market sale of 5,752 common shares valued at $56,455, to occur approximately on 08/22/2025, via Charles Schwab.

When were the shares being sold originally acquired?

The shares were acquired on 08/01/2017 in an open-market purchase with payment in cash.

How large is the proposed sale relative to INFU's outstanding shares?

The filing reports 20,425,964 shares outstanding; the 5,752-share block represents a very small fraction of total outstanding shares.

Did the filer report any other sales in the past three months?

No. The section for securities sold during the past three months states Nothing to Report.

Which broker is handling the proposed sale?

The broker listed is Charles Schwab Corp., 3000 Schwab Way, Westlake, TX.